• Need more information? Ask an information specialist at rc@aha.org

  • Enter your email address to subscribe to this blog and receive notifications of new posts by email.

    Join 331 other subscribers
  • Note:

    Information posted in this blog does not necessarily represent the views of the American Hospital Association
  • Archives

  • Categories

  • Top Posts

  • Top Rated Posts

CANCER: Merits of active surveillance – watchful waiting

The approach of active surveillance, which is increasingly common with prostate cancer patients, is becoming more frequently discussed as an option for selected patients with other types of slow-growing, early-stage cancers also.  The author, who himself opted for active surveillance, reviews reasons why watchful waiting may be becoming more often chosen – primarily due to therapy side effects and cost.  Considerations for insurers in framing their positions about active surveillance are covered.

Source: Kirkner, R.M. (2016, Oct.). Don’t just do something, stand there: How more types of cancer are lending themselves to active surveillance. Managed Care, 25(10), 25-28.  Click here: http://www.managedcaremag.com/archives/2016/10/don-t-just-do-something-stand-there-how-more-types-cancer-are-lending-themselves   Posted by AHA Resource Center (312) 422.2050, rc@aha.org

%d bloggers like this: